CombiGene Balance Sheet Health
Financial Health criteria checks 5/6
CombiGene has a total shareholder equity of SEK116.5M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK120.6M and SEK4.2M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr101.44m |
| Equity | kr116.46m |
| Total liabilities | kr4.16m |
| Total assets | kr120.61m |
Financial Position Analysis
Short Term Liabilities: COMBI's short term assets (SEK103.2M) exceed its short term liabilities (SEK4.2M).
Long Term Liabilities: COMBI's short term assets (SEK103.2M) do not cover its long term liabilities (SEK-1,000.0).
Debt to Equity History and Analysis
Debt Level: COMBI is debt free.
Reducing Debt: COMBI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COMBI has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: COMBI has sufficient cash runway for 2.1 years if free cash flow continues to grow at historical rates of 1.2% each year.